Les Recio

About Les Recio

Over twenty-five years of experience in investigative toxicology research in the areas of mutagenesis, toxicogenomics and regulatory based genotoxicity assessment using in vitro cell culture methods, in vivo studies in transgenic mouse strains, and genomic approaches. Authored more than 80 publications in the peer reviewed literature examining mode-of-action and identification of biomarkers of cytotoxicity, genotoxicity, and mutagenicity. In 2006, presented research at the National Research Council Workshops that focused on toxicogenomic responses to cytotoxic and genotoxic stress in human and mouse bone marrow stem cells. Appointed Chief Scientist at Integrated Laboratory Systems in 2014. Provide scientific leadership, vision and direction for ILS and ILS Genomics. Served on board of Councilors for the North Carolina Chapter of the Society of Toxicology (20••••08), and in 2006 was the President of the Genetic and Environmental Mutagenesis Society. In 2010, was appointed to the SOT Council on Diversity Initiatives and in 2012 elected President for the SOT’s Hispanic Organization for Toxicologist. In 2012 appointed to an OECD Expert Group charged with revising OECD 476 and the development of a new OECD Guidance on TK gene mutation. Serve on the Editorial Boards for Toxicological Sciences and Mutation Research – Reviews in Mutation Research.

Experience

1. Chief Scientific Officer

   Scitovation

   Apr 2022 — Present